OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
Jessica Wilcox, Adrienne Boire
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 45-67
Open Access | Times Cited: 14

Showing 14 citing articles:

Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer
Kelsey Pan, Kyle Concannon, Jing Li, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 716-732
Closed Access | Times Cited: 20

Autocrine CXCL1-CXCR2 Signaling Mediates Leptomeningeal Resistance to Radiation Therapy
Ahmed M. Osman, Ján Remšík, Jenna Snyder, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Brain metastases from lung cancer: recent advances and novel therapeutic opportunities
Stephen C. Layng, Alexis Betsock, Alireza Mansouri, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

The research progress on meningeal metastasis in solid tumors
Yun Yue, Yuqing Ren, Chunya Lu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Leptomeningeal Disease: Current Approaches and Future Directions
Uğur Sener, Jessica Wilcox, Adrienne Boire
Current Neurology and Neuroscience Reports (2025) Vol. 25, Iss. 1
Open Access

Radiotherapy and Systemic Treatment for Leptomeningeal Disease
K.M. Frechette, William G. Breen, Paul D. Brown, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1792-1792
Open Access | Times Cited: 2

Leptomeningeal metastatic disease: new frontiers and future directions
Ahmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 2

Dura immunity configures leptomeningeal metastasis immunosuppression for cerebrospinal fluid barrier invasion
Jiaxu Zhao, Rui Zeng, Xiaohui Li, et al.
Nature Cancer (2024) Vol. 5, Iss. 12, pp. 1940-1961
Closed Access | Times Cited: 2

The Spectrum of Headache in Leptomeningeal Metastases: A Comprehensive Review with Clinical Management Guidelines
Jessica Wilcox, Rachel Estrera, Adrienne Boire
Current Pain and Headache Reports (2023) Vol. 27, Iss. 11, pp. 695-706
Open Access | Times Cited: 3

Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature
Cindy M. Pabon, D.N. Yeboa, Barbara O’Brien, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 3, pp. 1331-1340
Open Access

The role of the neurologist in the diagnosis and treatment of brain metastases and carcinomatous meningitis
Alessia Pellerino, Diego Garbossa, Roberta Rudà, et al.
Revue Neurologique (2023) Vol. 179, Iss. 5, pp. 464-474
Closed Access | Times Cited: 1

Editorial: Advances in basic science and technology are bringing new flavor in neuro-oncology
Riccardo Soffietti
Current Opinion in Neurology (2023) Vol. 36, Iss. 6, pp. 541-543
Closed Access

Page 1

Scroll to top